Skip to main content
. 2016 Sep 18;2016(9):CD006992. doi: 10.1002/14651858.CD006992.pub2

Srivanichakorn 2015.

Methods 8‐week randomised controlled trial
Participants Participants with type 2 diabetes who had been treated with insulin for at least 3 years plus moderate to high doses of sulphonylureas
Interventions Withdrawal of sulphonylureas (insulin monotherapy) (n = 16) or continuation (n = 16) of sulphonylureas
Outcomes HbA1c, insulin secretion
Notes Need to determine whether participants were adequately controlled